Geode Capital Management
CVS icon

Geode Capital Management’s CVS Health CVS Stock Holding History

Geode Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.08B Buy
29,899,653
+440,611
+1% +$39.3M 0.16% 93
2026
Q1 		$2.11B Buy
29,459,042
+418,771
+1% +$32.3M 0.13% 126
2025
Q4 		$2.29B Buy
29,040,271
+52,506
+0.2% +$4.14M 0.14% 115
2025
Q3 		$2.18B Buy
28,987,765
+352,532
+1% +$24.2M 0.14% 117
2025
Q2 		$1.97B Buy
28,635,233
+675,824
+2% +$44.3M 0.14% 122
2025
Q1 		$1.89B Buy
27,959,409
+907,869
+3% +$54.3M 0.15% 119
2024
Q4 		$1.21B Buy
27,051,540
+689,867
+3% +$38.7M 0.09% 181
2024
Q3 		$1.65B Buy
26,361,673
+461,569
+2% +$26.9M 0.13% 127
2024
Q2 		$1.53B Buy
25,900,104
+518,029
+2% +$32.4M 0.13% 123
2024
Q1 		$2.02B Buy
25,382,075
+871,918
+4% +$66.6M 0.19% 97
2023
Q4 		$1.93B Buy
24,510,157
+580,027
+2% +$41.3M 0.2% 93
2023
Q3 		$1.67B Buy
23,930,130
+604,843
+3% +$42.9M 0.2% 92
2023
Q2 		$1.61B Buy
23,325,287
+363,384
+2% +$25.9M 0.19% 96
2023
Q1 		$1.7B Sell
22,961,903
-369,195
-2% -$31M 0.22% 86
2022
Q4 		$2.17B Sell
23,331,098
-43,323
-0.2% -$4.18M 0.3% 61
2022
Q3 		$2.23B Buy
23,374,421
+186,288
+0.8% +$18.4M 0.34% 49
2022
Q2 		$2.14B Buy
23,188,133
+761,218
+3% +$74.3M 0.31% 58
2022
Q1 		$2.26B Buy
22,426,915
+327,715
+1% +$34.4M 0.28% 63
2021
Q4 		$2.27B Buy
22,099,200
+408,181
+2% +$37.7M 0.27% 67
2021
Q3 		$1.84B Buy
21,691,019
+541,650
+3% +$45.4M 0.25% 75
2021
Q2 		$1.76B Buy
21,149,369
+678,557
+3% +$55.6M 0.24% 76
2021
Q1 		$1.54B Buy
20,470,812
+441,924
+2% +$32.2M 0.23% 76
2020
Q4 		$1.36B Buy
20,028,888
+275,609
+1% +$17.9M 0.23% 78
2020
Q3 		$1.15B Buy
19,753,279
+107,954
+0.5% +$6.72M 0.23% 82
2020
Q2 		$1.27B Buy
19,645,325
+399,947
+2% +$25.2M 0.27% 67
2020
Q1 		$1.14B Buy
19,245,378
+577,235
+3% +$38.5M 0.3% 62
2019
Q4 		$1.38B Buy
18,668,143
+337,843
+2% +$23.7M 0.29% 65
2019
Q3 		$1.15B Buy
18,330,300
+365,253
+2% +$21.6M 0.27% 69
2019
Q2 		$977M Buy
17,965,047
+397,185
+2% +$21.4M 0.24% 78
2019
Q1 		$946M Buy
17,567,862
+1,105,570
+7% +$68.2M 0.25% 81
2018
Q4 		$1.08B Buy
16,462,292
+4,376,604
+36% +$327M 0.33% 58
2018
Q3 		$950M Sell
12,085,688
-121,462
-1% -$8.68M 0.27% 67
2018
Q2 		$784M Buy
12,207,150
+758,150
+7% +$50M 0.24% 72
2018
Q1 		$711M Buy
11,449,000
+580,669
+5% +$41.7M 0.23% 83
2017
Q4 		$786M Buy
10,868,331
+235,357
+2% +$17.1M 0.27% 70
2017
Q3 		$863M Buy
10,632,974
+246,659
+2% +$19.5M 0.32% 58
2017
Q2 		$834M Buy
10,386,315
+546,364
+6% +$43.1M 0.33% 57
2017
Q1 		$771M Buy
9,839,951
+414,867
+4% +$33.1M 0.32% 58
2016
Q4 		$743M Buy
9,425,084
+648,919
+7% +$52.5M 0.35% 53
2016
Q3 		$780M Buy
8,776,165
+192,933
+2% +$18.2M 0.39% 45
2016
Q2 		$820M Sell
8,583,232
-333,808
-4% -$33.3M 0.45% 42
2016
Q1 		$923K Buy
8,917,040
+77,690
+0.9% +$7.55M 0.49% 39
2015
Q4 		$862M Sell
8,839,350
-8,309
-0.1% -$814K 0.49% 40
2015
Q3 		$852M Sell
8,847,659
-106,587
-1% -$11.2M 0.52% 36
2015
Q2 		$937M Sell
8,954,246
-297,318
-3% -$30.4M 0.54% 33
2015
Q1 		$953M Buy
9,251,564
+293,583
+3% +$29.7M 0.55% 33
2014
Q4 		$862M Buy
8,957,981
+208,821
+2% +$18.4M 0.51% 36
2014
Q3 		$695M Sell
8,749,160
-145,076
-2% -$11.4M 0.45% 38
2014
Q2 		$670M Sell
8,894,236
-222,285
-2% -$16.8M 0.43% 39
2014
Q1 		$682M Buy
9,116,521
+73,537
+0.8% +$5.19M 0.46% 38
2013
Q4 		$647M Buy
9,042,984
+223,177
+3% +$14.3M 0.45% 41
2013
Q3 		$500M Buy
8,819,807
+316,530
+4% +$18.9M 0.4% 47
2013
Q2 		$486M Buy
+8,503,277
New +$493M 0.43% 43

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Geode Capital Management's CVS Position: Q2 2026 in Review

Geode Capital Management increased its CVS Health (CVS) stake by 1.5% in Q2 2026, buying an estimated $39.3M and bringing the position to 29,899,653 shares worth $3.08B. The position accounts for 0.16% of the portfolio, ranked #93.

Geode Capital Management first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. 1,737 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Geode Capital Management held 29,899,653 shares of CVS Health worth $3.08B as of Q2 2026.
  • Geode Capital Management bought 440,611 CVS Health shares in Q2 2026, an estimated $39.3M.
  • CVS Health made up 0.16% of Geode Capital Management's portfolio in Q2 2026, its #93 holding.
  • Geode Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • 1,737 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.